These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 25397420)

  • 1. Analysis of transmitted drug resistance and HIV-1 subtypes using dried serum spots of recently HIV-infected individuals in 2013 in Germany.
    Andrea H; Alexandra H; Claudia SH; Ruth Z; Osamah H; Norbert B; Claudia K
    J Int AIDS Soc; 2014; 17(4 Suppl 3):19670. PubMed ID: 25397420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increasing proportions of HIV-1 non-B subtypes and of NNRTI resistance between 2013 and 2016 in Germany: Results from the national molecular surveillance of new HIV-diagnoses.
    Hauser A; Hofmann A; Meixenberger K; Altmann B; Hanke K; Bremer V; Bartmeyer B; Bannert N
    PLoS One; 2018; 13(11):e0206234. PubMed ID: 30408827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transmitted HIV drug resistance in antiretroviral-treatment-naive patients from Poland differs by transmission category and subtype.
    Parczewski M; Leszczyszyn-Pynka M; Witak-Jędra M; Maciejewska K; Rymer W; Szymczak A; Szetela B; Gąsiorowski J; Bociąga-Jasik M; Skwara P; Garlicki A; Grzeszczuk A; Rogalska M; Jankowska M; Lemańska M; Hlebowicz M; Barałkiewicz G; Mozer-Lisewska I; Mazurek R; Lojewski W; Grąbczewska E; Olczak A; Jabłonowska E; Clark J; Urbańska A
    J Antimicrob Chemother; 2015 Jan; 70(1):233-42. PubMed ID: 25248322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. National molecular surveillance of recently acquired HIV infections in Germany, 2013 to 2014.
    Hauser A; Hofmann A; Hanke K; Bremer V; Bartmeyer B; Kuecherer C; Bannert N
    Euro Surveill; 2017 Jan; 22(2):. PubMed ID: 28105988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surveillance of recent HIV infections among newly diagnosed HIV cases in Germany between 2008 and 2014.
    Hofmann A; Hauser A; Zimmermann R; Santos-Hövener C; Bätzing-Feigenbaum J; Wildner S; Kücherer C; Bannert N; Hamouda O; Bremer V; Bartmeyer B
    BMC Infect Dis; 2017 Jul; 17(1):484. PubMed ID: 28693564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transmitted drug-resistance in human immunodeficiency virus-infected adult population in El Salvador, Central America.
    Holguín Á; Yebra G; Martín L; de Pineda AT; Ruiz LE; Quezada AY; Nieto AI; Escobar G
    Clin Microbiol Infect; 2013 Dec; 19(12):E523-32. PubMed ID: 23782115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New trends of primary drug resistance among HIV type 1-infected men who have sex with men in Liaoning Province, China.
    Zhao B; Han X; Dai D; Liu J; Ding H; Xu J; Chu Z; Bice T; Diao Y; Shang H
    AIDS Res Hum Retroviruses; 2011 Oct; 27(10):1047-53. PubMed ID: 21417755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-1 transmission networks across Cyprus (2010-2012).
    Kostrikis LG; Hezka J; Stylianou DC; Kostaki E; Andreou M; Kousiappa I; Paraskevis D; Demetriades I
    PLoS One; 2018; 13(4):e0195660. PubMed ID: 29684083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiological and Molecular Characteristics of HIV-1 Infection in a Sample of Men Who Have Sex With Men in Brazil: Phylogeography of Major Subtype B and F1 Transmission Clusters.
    Silva ÁMDCE; Reis MNDG; Marinho TA; de Freitas NR; Teles SA; de Matos MAD; Carneiro MADS; Bello G; Stefani MMA; Martins RMB
    Front Microbiol; 2020; 11():589937. PubMed ID: 33329467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and circulation patterns of variant, atypical and resistant HIV in Los Angeles County (2007-2009).
    Sey K; Ma Y; Lan YC; Song N; Hu YW; Ou Y; Frye D
    J Med Virol; 2014 Oct; 86(10):1639-47. PubMed ID: 24976142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and optimization of an internally controlled dried blood spot assay for surveillance of human immunodeficiency virus type-1 drug resistance.
    Buckton AJ; Bissett SL; Myers RE; Beddows S; Edwards S; Cane PA; Pillay D
    J Antimicrob Chemother; 2008 Dec; 62(6):1191-8. PubMed ID: 18927229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of transmitted antiretroviral resistance and distribution of HIV-1 subtypes among patients with recent infection in Catalonia (Spain) between 2003 and 2005.
    Romero A; Sued O; Puig T; Esteve A; Pumarola T; Casabona J; González V; Matas L; Tural C; Rodrigo I; Margall N; Domingo P; Casanova A; Ferrer E; Caballero E; Ribera E; Farré J; Puig T; Amengual MJ; Navarro G; Prat JM; Masabeu A; Simó JM; Villaverde CA; Barrufet P; Sauca MG; Ortin X; Ortí A; Navarro R; Euras JM; Vilaró J; Villà MC; Montull S; Vilanova C; Pujol F; Díaz O; Miró JM;
    Enferm Infecc Microbiol Clin; 2011; 29(7):482-9. PubMed ID: 21543135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1 transmitted drug resistance and genetic diversity among patients from Piauí State, Northeast Brazil.
    Moura ME; da Guarda Reis MN; Lima YA; Eulálio KD; Cardoso LP; Stefani MM
    J Med Virol; 2015 May; 87(5):798-806. PubMed ID: 25649362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and evaluation of an assay for HIV-1 protease and reverse transcriptase drug resistance genotyping of all major group-M subtypes.
    Aitken SC; Kliphuis A; Wallis CL; Chu ML; Fillekes Q; Barth R; Stevens W; Rinke de Wit TF; Schuurman R
    J Clin Virol; 2012 May; 54(1):21-5. PubMed ID: 22306272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.
    Broz D; Wejnert C; Pham HT; DiNenno E; Heffelfinger JD; Cribbin M; Krishna N; Teshale EH; Paz-Bailey G;
    MMWR Surveill Summ; 2014 Jul; 63(6):1-51. PubMed ID: 24990587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short communication: Prevalence of HIV-1 transmitted drug resistance in Liberia.
    Loubet P; Charpentier C; Visseaux B; Nuta C; Adu E; Chapplain JM; Baysah M; Walters-Doe S; Tattevin P; Peytavin G; Yazdanpanah Y; Descamps D
    AIDS Res Hum Retroviruses; 2014 Sep; 30(9):863-6. PubMed ID: 24946849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Robust and sensitive subtype-generic HIV-1 pol genotyping for use with dried serum spots in epidemiological studies.
    Hauser A; Meixenberger K; Machnowska P; Fiedler S; Hanke K; Hofmann A; Bartmeyer B; Bremer V; Bannert N; Kuecherer C
    J Virol Methods; 2018 Sep; 259():32-38. PubMed ID: 29859195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transmitted antiretroviral drug resistance in individuals with newly diagnosed HIV infection: South Carolina 2005-2009.
    Youmans E; Tripathi A; Albrecht H; Gibson JJ; Duffus WA
    South Med J; 2011 Feb; 104(2):95-101. PubMed ID: 21206421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different trends of transmitted HIV-1 drug resistance in Madrid, Spain, among risk groups in the last decade.
    Yebra G; Delgado R; Pulido F; Rubio R; Galán JC; Moreno S; Holguín Á
    Arch Virol; 2014 May; 159(5):1079-87. PubMed ID: 24297490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Primary drug resistance of HIV-1 infected men who have sex with men in Shenzhen, China].
    Zhao GL; Yu W; Cai YM; Wang F; Hong FC; Jiang WN; Li YL; Peng Y; Zhang CL; Zhang JJ; Feng TJ
    Zhonghua Yi Xue Za Zhi; 2012 May; 92(17):1165-9. PubMed ID: 22883002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.